Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia

Show simple item record Rosenberg, Philip S. en_US Alter, Blanche P. en_US Link, Daniel C. en_US Stein, Steven en_US Rodger, Elin en_US Bolyard, Audrey A. en_US Aprikyan, Andrew A. en_US Bonilla, Mary A. en_US Dror, Yigal en_US Kannourakis, George en_US Newburger, Peter E. en_US Boxer, Laurence A. en_US Dale, David C. en_US 2010-06-01T20:41:20Z 2010-06-01T20:41:20Z 2008-01 en_US
dc.identifier.citation Rosenberg, Philip S.; Alter, Blanche P.; Link, Daniel C.; Stein, Steven; Rodger, Elin; Bolyard, Audrey A.; Aprikyan, Andrew A.; Bonilla, Mary A.; Dror, Yigal; Kannourakis, George; Newburger, Peter E.; Boxer, Laurence A.; Dale, David C. (2008). "Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia." British Journal of Haematology 140(2): 210-213. <> en_US
dc.identifier.issn 0007-1048 en_US
dc.identifier.issn 1365-2141 en_US
dc.identifier.uri en_US
dc.format.extent 148954 bytes
dc.format.extent 3109 bytes
dc.format.mimetype application/pdf
dc.format.mimetype text/plain
dc.publisher Blackwell Publishing Ltd en_US
dc.rights Journal Compilation 2007 Blackwell Publishing Ltd No claim to original US government works en_US
dc.subject.other Severe Congenital Neutropenia en_US
dc.subject.other Neutrophil Elastase ELA2 en_US
dc.subject.other Acute Myeloid Leukaemia en_US
dc.subject.other Myelodysplastic Syndromes en_US
dc.subject.other Granulocyte Colony-stimulating Factor en_US
dc.title Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia en_US
dc.type Article en_US
dc.subject.hlbsecondlevel Oncology and Hematology en_US
dc.subject.hlbtoplevel Health Sciences en_US
dc.description.peerreviewed Peer Reviewed en_US
dc.contributor.affiliationum Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI, USA en_US
dc.contributor.affiliationother Biostatistics Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health en_US
dc.contributor.affiliationother Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, MD en_US
dc.contributor.affiliationother Department of Medicine, Washington University School of Medicine, St Louis, MO en_US
dc.contributor.affiliationother Department of Medicine, University of Washington, Seattle, WA en_US
dc.contributor.affiliationother Department of Pediatric Hematology Oncology, St. Joseph’s Children’s Hospital, Paterson, NJ, USA en_US
dc.contributor.affiliationother Hospital for Sick Children, Toronto, ON, Canada en_US
dc.contributor.affiliationother Ballarat Cancer Research Centre, University of Ballarat, Wendouree, Vic., Australia en_US
dc.contributor.affiliationother Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA en_US
dc.identifier.pmid 18028488 en_US
dc.identifier.doi 10.1111/j.1365-2141.2007.06897.x en_US
dc.identifier.source British Journal of Haematology en_US
dc.identifier.citedreference Ancliff, P.J. ( 2003 ) Congenital neutropenia. Blood Reviews, 17, 209 – 216. en_US
dc.identifier.citedreference Ancliff, P.J., Gale, R.E., Liesner, R., Hann, I. & Linch, D.C. ( 2003 ) Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. British Journal of Haematology, 120, 685 – 690. en_US
dc.identifier.citedreference Bellanne-Chantelot, C., Clauin, S., Leblanc, T., Cassinat, B., Rodrigues-Lima, F., Beaufils, S., Vaury, C., Barkaoui, M., Fenneteau, O., Maier-Redelsperger, M., Chomienne, C. & Donadieu, J. ( 2004 ) Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood, 103, 4119 – 4125. en_US
dc.identifier.citedreference Boxer, L.A. & Newburger, P.E. ( 2007 ) A molecular classification of congenital neutropenia syndromes. Pediatric Blood & Cancer, 49, 609 – 614. en_US
dc.identifier.citedreference Dale, D.C., Bonilla, M.A., Davis, M.W., Nakanishi, A.M., Hammond, W.P., Kurtzberg, J., Wang, W., Jakubowski, A., Winton, E. & Lalezari, P. ( 1993 ) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood, 81, 2496 – 2502. en_US
dc.identifier.citedreference Dale, D.C., Person, R.E., Bolyard, A.A., Aprikyan, A.G., Bos, C., Bonilla, M.A., Boxer, L.A., Kannourakis, G., Zeidler, C., Welte, K., Benson, K.F. & Horwitz, M. ( 2000 ) Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood, 96, 2317 – 2322. en_US
dc.identifier.citedreference Dale, D.C., Cottle, T.E., Fier, C.J., Bolyard, A.A., Bonilla, M.A., Boxer, L.A., Cham, B., Freedman, M.H., Kannourakis, G., Kinsey, S.E., Davis, R., Scarlata, D., Schwinzer, B., Zeidler, C. & Welte, K. ( 2003 ) Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. American Journal of Hematology, 72, 82 – 93. en_US
dc.identifier.citedreference Horwitz, M.S., Duan, Z., Korkmaz, B., Lee, H.H., Mealiffe, M.E. & Salipante, S.J. ( 2007 ) Neutrophil elastase in cyclic and severe congenital neutropenia. Blood, 109, 1817 – 1824. en_US
dc.identifier.citedreference Klein, C., Grudzien, M., Appaswamy, G., Germeshausen, M., Sandrock, I., Schaffer, A.A., Rathinam, C., Boztug, K., Schwinzer, B., Rezaei, N., Bohn, G., Melin, M., Carlsson, G., Fadeel, B., Dahl, N., Palmblad, J., Henter, J.I., Zeidler, C., Grimbacher, B. & Welte, K. ( 2007 ) HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nature Genetics, 39, 86 – 92. en_US
dc.identifier.citedreference Rosenberg, P.S., Alter, B.P., Bolyard, A.A., Bonilla, M.A., Boxer, L.A., Cham, B., Fier, C., Freedman, M., Kannourakis, G., Kinsey, S., Schwinzer, B., Zeidler, C., Welte, K. & Dale, D.C. ( 2006 ) The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood, 107, 4628 – 4635. en_US
dc.identifier.citedreference Touw, I.P. & Bontenbal, M. ( 2007 ) Granulocyte colony-stimulating factor: key (f)actor or innocent bystander in the development of secondary myeloid malignancy? Journal of the National Cancer Institute, 99, 183 – 186. en_US
dc.owningcollname Interdisciplinary and Peer-Reviewed
 Show simple item record

This item appears in the following Collection(s)

Search Deep Blue

Advanced Search

Browse by

My Account


Available Now

MLibrary logo